#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Pharmacological Treatment of Acute Coronary Syndromes


Authors: F. Holm;  M. Aschermann 1
Authors‘ workplace: Kardiologické oddělení, Krajská nemocnice Liberec 1II. interní klinika 1. LF UK a VFN, Praha
Published in: Čas. Lék. čes. 2003; : 456-459
Category:

Overview

Acute coronary syndromes (ACS) are caused by neoinclusive thrombosis of the coronary artery. Arterial atherothrombosisusually results from a cracked atheroma plate and includes platelet and plasmatic component ofcoagulation. The aim of pharmacological treatment is to influence activated platelets and plasma procoagulantactivity. Several clinical studies have demonstrated the benefits of antithrombotic treatment by acetylsalicylic acid,clopidogrel and by blockers of platelet receptors IIb/IIIa. In ACS anticoagulant therapy the non-fractionated heparinare replace ed by low-molecular heparins. The new standard in ACS therapy should become a combination of theacetylsalicylic acid, enoxaparine and clopidogrel. Blockers of platelet receptors IIb/IIIa should be given namely topatients indicated for the early invasive treatment.

Key words:
acute coronary syndrome, pharmacotherapy.

Full text is not available online.
If interested in a scan of this journal, contact NTO ČLS JEP.

Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental Hygienist

Article was published in

Journal of Czech Physicians


Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#